Control group (severe patients):Routine treatment

2 trials

Sponsors

The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang University

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Early Phase 1

Study for the efficacy of Kangguan No. 1-3 prescription in the treatment of novel coronavirus pneumonia (COVID19)

Active, not recruitingITMCTR2000003052

The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang UniversityNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-26Updated: 2023-02-20

Study for the efficacy of Kangguan No. 1-3 prescription in the treatment of novel coronavirus pneumonia (COVID19)

Active, not recruitingChiCTR2000030215

The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang UniversityNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-26Updated: 2020-03-02